mDETECT is among the four companies selected for BioCreate, the program funded by Ontario Genomics, a non-profit organization funded by the Government of Ontario and FedDev Ontario. mDetect has developed a blood test that detects six common cancers and provides doctors with information about how well a patient has responded to treatment.
mDETECT is an OBIO® member, an alumnus of our WiHI program, and presented at the OBIO® Investment Summit.